RIGOTTI, PAOLO
 Distribuzione geografica
Continente #
AS - Asia 2.097
NA - Nord America 1.762
EU - Europa 705
SA - Sud America 347
AF - Africa 42
AN - Antartide 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.957
Nazione #
US - Stati Uniti d'America 1.707
SG - Singapore 955
CN - Cina 745
BR - Brasile 302
RO - Romania 269
HK - Hong Kong 237
RU - Federazione Russa 107
IT - Italia 94
DE - Germania 63
VN - Vietnam 53
GB - Regno Unito 39
CA - Canada 32
IN - India 25
ZA - Sudafrica 25
SE - Svezia 21
FI - Finlandia 20
AR - Argentina 19
MX - Messico 19
NL - Olanda 19
PL - Polonia 19
AT - Austria 15
BD - Bangladesh 14
ES - Italia 11
IQ - Iraq 11
TR - Turchia 11
EC - Ecuador 10
JP - Giappone 10
FR - Francia 9
PK - Pakistan 7
ID - Indonesia 6
LT - Lituania 6
AE - Emirati Arabi Uniti 4
MA - Marocco 4
UZ - Uzbekistan 4
CL - Cile 3
CO - Colombia 3
EG - Egitto 3
KE - Kenya 3
LB - Libano 3
OM - Oman 3
TN - Tunisia 3
UA - Ucraina 3
VE - Venezuela 3
AQ - Antartide 2
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
PE - Perù 2
UY - Uruguay 2
AO - Angola 1
AU - Australia 1
BE - Belgio 1
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
MK - Macedonia 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.957
Città #
Dallas 1.160
Singapore 479
Hong Kong 237
Shanghai 214
Hefei 115
Ashburn 98
Beijing 70
Los Angeles 36
Guangzhou 35
Boardman 30
New York 30
Moscow 29
São Paulo 24
Johannesburg 22
Milan 22
Brooklyn 20
Ho Chi Minh City 19
Chennai 18
Munich 17
Nuremberg 17
Amsterdam 15
Shenzhen 15
Warsaw 15
Rome 14
London 13
Assago 12
Helsinki 12
Montreal 12
Rio de Janeiro 12
Hanoi 11
Santa Clara 11
Stockholm 11
Boston 10
Poplar 10
Tokyo 10
Toronto 9
Belo Horizonte 8
Chicago 8
Jiaxing 8
San Francisco 8
Charlotte 7
Manchester 7
Mexico City 7
Paris 7
Phoenix 7
Seattle 7
Brasília 6
Cesano Boscone 6
Guarulhos 6
Porto Alegre 6
Quito 6
Washington 6
Wuxi 6
Atlanta 5
Baghdad 5
Brescia 5
Campinas 5
Frankfurt am Main 5
Fuzhou 5
Lawrence 5
Princeton 5
Reston 5
Vienna 5
Ankara 4
Buenos Aires 4
Curitiba 4
Denver 4
Dhaka 4
Fortaleza 4
Guayaquil 4
Houston 4
Lappeenranta 4
Orem 4
Tashkent 4
Turku 4
Uberlândia 4
West Jordan 4
Carney 3
Changsha 3
Florianópolis 3
Foshan 3
Kassel 3
Klosterneuburg 3
Modena 3
Muscat 3
Nairobi 3
Ottawa 3
Palhoça 3
Piracicaba 3
Salvador 3
Sorocaba 3
Wolfhagen 3
Abu Dhabi 2
Augusta 2
Baku 2
Basra 2
Betim 2
Birmingham 2
Buffalo 2
Bắc Giang 2
Totale 3.167
Nome #
105.3: Analysis of Autoimmune Re-activation After COVID-19 mRNA Vaccination in Pancreas Transplant Recipients 1.335
Kidney exchange strategies: new aspects and applications with a focus on deceased donor-initiated chains 60
First World Consensus Conference on Pancreas Transplantation: Part II - recommendations 60
COVID-19 and kidney transplantation: an Italian Survey and Consensus 59
C4d-positive renal allograft rejection biopsies in cyclosporine-treated patients:single-center incidence and outcome 58
Acute rejection features in dual kidney transplant recipients fromelderly donors: comparison of calcineurin inhibitor-based and calcineurininhibitor-free immunosuppressive protocols 54
Assessment of Adherence To Medical Regimen After Solid Organ Transplantation: the Experience of Padova University Hospital 54
Advantages of Using a Web-based Digital Platform for Kidney Preimplantation Biopsies 53
Kidney Donation after circulatory death: The Veneto Region experience in Italy 52
ADVANTAGES OF PSI plus LOW-DOSE CNI VS PSI ALONE IN DUAL KIDNEY TRANSPLANTATION (DKT) FROM ELDERLY DONORS 50
A RARE CAUSE OF ULCERATIVE LESION OF THE PALATE AND FEVER IN A RENAL-TRANSPLANT RECIPIENT 50
A randomized trial of everolimus and low-dose cyclosporine in renal transplantation: with or without steroids? 50
Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins 49
Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment 49
"Why can't I give you my organs after my heart has stopped beating?" An overview of the main clinical, organisational, ethical and legal issues concerning organ donation after circulatory death in Italy 48
A single-center experience with 200 dual kidney transplantations 48
The era of the new directly acting antivirals: Has the time come for kidney transplant only in compensated cirrhosis? 48
First world consensus conference on pancreas transplantation: Part I—Methods and results of literature search 47
Autosomal Dominant Polycystic Kidney Disease 47
Correction to: Effects of immune suppression for transplantation on inflammatory colorectal cancer progression (Oncogenesis, (2018), 7, 6, (46), 10.1038/s41389-018-0055-5) 46
Alefacept Combined With Tacrolimus, Mycophenolate Mofetil and Steroids in De Novo Kidney Transplantation: A Randomized Controlled Trial 45
ABCB1 Genotypes Predict Cyclosporine-Related Adverse Events and Kidney Allograft Outcome 45
Immune activation, immune senescence and levels of Epstein Barr Virus in kidney transplant patients: Impact of mTOR inhibitors 45
LONG TERM RESULTS OF A LARGE EXPERIENCE OF DOUBLE KIDNEY TRANSPLANTATION (DKT) PERFORMED AT A SINGLE CENTER 44
Comparison of CMV ELISPOT and CMV Quantiferon™ interferon-γ releasing assays in assessing risk of CMV infection in kidney transplant recipients 42
Coronary Microvascular Dysfunction Predicts Long-Term Outcome in Simultaneous Pancreas-Kidney Transplantation 42
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial 42
Exploring definitions of graft pancreatitis following pancreas transplantation: A scoping review 41
Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: A randomized phase III study 41
[Living donor kidney transplant: the surgical procedure] 41
Surgical overview on kidney and pancreas transplantation 40
Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies 39
DNA Methylation - and Telomere - Based Biological Age Estimation as Markers of Biological Aging in Donors Kidneys 38
Erratum: Optimizing utilization of kidneys from deceased donors over 60 years: Five-year outcomes after implementation of a combined clinical and histological allocation algorithm (Transplant International (2013) 26 (833)) 38
MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma 38
Surgical complications in simultaneous pancreas and kidney transplantation (SPK) with enteric exocrine drainage and systemic venous drainage 37
Pulse pressure variation guided fluid therapy during kidney transplantation: a randomized controlled trial 37
Telemedicine monitoring in the follow-up of kidney transplant recipients: consensus indications from an Italian panel of surgeons and nephrologists after the COVID-19 experience 37
Lower Urinary Tract Symptoms in Kidney Transplant Recipients and Timing of Treatment With TURP: Impact on Renal Graft Survival and Function 37
Headache in kidney transplantation 36
Persistent Secondary Hyperparathyroidism and Vertebral Fractures in Kidney Transplantation: Role of Calcium-Sensing Receptor Polymorphisms and Vitamin D Deficiency 36
Ex Vivo open reconstruction of hilar renal artery aneurysms: a silngle-center experience 35
MAXIMIZING THE SUCCESS OF TRANSPLANTATION WITH KIDNEYS FROM OLDER DONORS: LONG-TERM RESULTS OF A MULTICENTER, PROSPECTIVE STUDY 34
Laparoscopic and robot-assisted nephrectomy 33
Outcome and quality of life of patients with augmented bladder or urinary diversion after kidney transplantation 33
Transplantation: can a single criterion determine the use of ECD kidneys? 33
In vitro and in vivoimmunomodulatory effects of cobalt protoporphyrin administered in combinationwith immunosuppressive drugs 33
Perioperative strategies: Taking care of the elderly patient with severe advanced comorbidities needing acute surgery 33
Pathophysiology of Post Transplant Hypertension in Kidney Transplant: Focus on Calcineurin Inhibitors Induced Oxidative Stress and Renal Sodium Retention and Implications with RhoA/Rho Kinase Pathway 32
DUAL KIDNEY TRANSPLANTATION FROM ELDERLY DONORS: LONG TERM OUTCOME AND HISTOLOGICAL FEATURES 32
How Long Does It Take to Acquire Mastery of Performance in Laparoscopic Living Donor Nephrectomy? A Center-Based and Surgeon-Based Operative Time CUSUM Analysis 32
Glomerulitis and endothelial cell enlargement in C4d(+) and C4d(-) acute rejections of renal transplant patients 31
Early Appearance of De Novo Anti-HLA Antibodies Following Renal Transplantation: Preliminary Results of a Prospective Multicenter Study 31
Refinement of a primate model: Long-term enteral administration of drugs or nutritional supplementary by a subcutaneously implanted port 31
SEMEIOTICA CHIRURGICA 31
Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review 31
Desensitization with plasmapheresis and anti-Cd20 for ABO incompatible kidney transplantation from living donor: experience of a single center in Italy 30
Everolimus Associated With Low-Dose Calcineurin Inhibitors, an Option in Kidney Transplant Recipients of Very Old Donors 30
Refinement of a primate xenotransplantation model: application of a subcutaneously implanted port as a means of gastric nutrition 30
Kidney Autotransplantation for Renal Artery Aneurysm: Case Series and a Systematic Review 30
Everolimus with very low-exposure cyclosporine A in de Novo kidney transplantation: A multicenter, randomized, controlled trial 30
Everolimus and Minimization of Cyclosporine in Renal Transplantation: 24-Month Follow-Up of the EVEREST Study 29
Deceased donor-initiated Chains: first report of a successful deliberate case and its ethical implications 29
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation 29
Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial 29
EARLY APPEARANCE OF DE NOVO ANTI-HLA ANTIBODIES FOLLOWING RENAL TRANSPLANTATION: PRELIMINARY RESULTS OF A MULTICENTER STUDY 29
Epstein-Barr virus-associated gastric carcinoma 33 years after kidney transplantation 29
Non-compliance after solid organ transplantation: the experience of Padua University Hospital 29
MicroRNAs: nuovi biomarcatori predittivi di sviluppo di insufficienza renale cronica e ipertensione arteriosa nei pazienti sottoposti a nefrectomia radicale per carcinoma renale. 29
Dual kidney transplantation after liver transplantation: a good option to rescue a patient from dialysis 28
Immunosoppressive Therapy and Risk of Post-Transplant Malignancies after Kidney Transplantation: Italian Multicentric Study 28
The debate on preemptive transplantation: queries and limits 28
Optimising utilisation of kidneys from deceased donors over 60 years: Five–year outcomes after implementation of a combined clinical and histological allocation algorithm 28
Therapeutic apheresis in kidney AB0 incompatible transplantation 27
Excellent Performance of Kidneys from Octogenarian Donors Transplanted as Dual Kidney Transplantation 27
EVALUATION OF HUMAN CYTOMEGALOVIRUS (CMV) SPECIFIC T-CELL RESPONSES PREDICTS EARLY AND LATE ONSET CMV INFECTION IN A COHORT OF KIDNEY TRANSPLANT RECIPIENTS 27
Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials 27
Outcome of Renal Transplantation from Very Old Donors 27
Physical Activity in Solid Organ Transplant Recipients: Organizational Aspects and Preliminary Results of the Italian Project 27
Effects of immune suppression for transplantation on inflammatory colorectal cancer progression 27
Erratum: Comparison of cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV quantiferon gamma interferon-releasing assays in assessing risk of CMV infection in kidney transplant recipients (Journal of Clinical Microbiology (2013) 51:8 (2501-2507)) 27
PROLIFERATION SIGNAL INHIBITORS (PSI) CAN BE SAFELY USED AB INITIO AFTER DUAL KIDNEY TRANSPLANTATION (DKT) FROM ELDERLY DONORS (ED) 26
Organ Donors with Small Renal Cancer: Report of 3 Cases 26
Risk of renal cell cancer in people immunodepressed after solid organ transplant: Results from an Italian multicenter cohort study 26
EVALUATION OF CORONARY MICROVASCULAR FUNCTION BY CORONARY FLOW RESERVE (CFR) MEASUREMENT IN SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANTATION (SPK) ALLOGRAFT RECIPIENTS 26
Glomerular C4d Immunoreactivity in Acute Rejection Biopsies of Renal Transplant Patients 26
Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patients 26
Potential role of effector memory T cells in chronic T cell-mediated kidney graft rejection 25
Pharmacokinetics for Once- Versus Twice-Daily Tacrolimus Formulations in De Novo Kidney Transplantation: A Randomized, Open-Label Trial 25
Transplantation: Optimizing outcomes in elderly kidney transplant recipients 25
Sirolimus-Based Therapy For Kidney Transplantation From Expanded Criteria Donors 25
Evaluation of Endothelial Cell Enlargement in Glomerulitis 25
CYCLOSPORIN A AND TACROLIMUS, COMBINED WITH MYCOPHENOLIC ACID, ARE EQUALLY EFFECTIVE IN PREVENTING THE ONSET OF DE NOVO ANTI-HLA ANTIBODIES 25
Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients 25
Increased cancer risk in patients undergoing dialysis: a population-based cohort study in North-Eastern Italy 24
Sotrastaurin, a Novel Small Molecule Inhibiting Protein Kinase C: First Clinical Results in Renal-Transplant Recipients 24
Glomerulitis in acute rejection of renal transplant patients 24
Safety of everolimus with reduced calcineurin inhibitor exposure in de novo kidney transplants: An analysis from the randomized transform study 24
Risk of de novo cancers after transplantation: Results from a cohort of 7217 kidney transplant recipients, Italy 1997–2009 24
Evaluation of coronary microvascular function by coronary flow reserve (cfr) measurement in simultaneous pancreas and kidney transplantation (spk) allograft recipients 23
Totale 4.827
Categoria #
all - tutte 26.189
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.189


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 1 0 0 0 0 0
2021/20224 1 0 1 1 0 0 0 0 1 0 0 0
2022/202328 13 4 2 0 0 3 0 0 2 1 1 2
2023/2024329 1 1 0 0 0 0 0 145 34 8 33 107
2024/20251.990 187 18 21 98 214 151 542 150 234 103 120 152
2025/20262.780 383 549 957 536 303 52 0 0 0 0 0 0
Totale 5.134